Yumanity Therapeutics (FRA:8IY) Operating Cash Flow per Share : €-2.21 (TTM As of Sep. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Operating Cash Flow per Share?

Yumanity Therapeutics's operating cash flow per share for the three months ended in Sep. 2022 was €-0.34. Yumanity Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2022 was €-2.21.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Yumanity Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

FRA:8IY's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Yumanity Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Yumanity Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Operating Cash Flow per Share Chart

Yumanity Therapeutics Annual Data

Trend

Dec19

Dec20

Dec21

Operating Cash Flow per Share

-2.43

-6.26

-4.21

Yumanity Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Operating Cash Flow per Share	Get a 7-Day Free Trial							-0.68	-0.74	-0.66	-0.46	-0.34

Competitive Comparison of Yumanity Therapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Yumanity Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yumanity Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yumanity Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Yumanity Therapeutics's Price-to-Operating-Cash-Flow falls into.

Yumanity Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Yumanity Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (A: Dec. 2021 )	=	Cash Flow from Operations (A: Dec. 2021 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2021 )
	=	-43.29	/	10.283
	=	-4.21

Yumanity Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (Q: Sep. 2022 )	=	Cash Flow from Operations (Q: Sep. 2022 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2022 )
	=	-3.717	/	10.856
	=	-0.34

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.21

Yumanity Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Yumanity Therapeutics (FRA:8IY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Guest Street, Suite 4410, Boston, MA, USA, 02135

Website

https://www.yumanity.com

Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines